世界のプロカルシトニン販売市場2021

QYResearchが発行した調査報告書(QYR21JN7860)
◆英語タイトル:Global Procalcitonin (CAS 56645-65-9) Sales Market Report 2021
◆商品コード:QYR21JN7860
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月7日
◆ページ数:149
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥552,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥828,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,104,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界のプロカルシトニン市場について種類別(プロカルシトニン抗原、プロカルシトニン抗体)、用途別(医療産業、科学研究、獣医)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・プロカルシトニン市場の概要
・世界の主要地域別プロカルシトニン市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界のプロカルシトニン市場規模2016-2021:種類別(プロカルシトニン抗原、プロカルシトニン抗体)
・世界のプロカルシトニン市場予測2012-2027:種類別(プロカルシトニン抗原、プロカルシトニン抗体)
・世界のプロカルシトニン市場規模2016-2021:用途別(医療産業、科学研究、獣医)
・世界のプロカルシトニン市場予測2012-2027:用途別(医療産業、科学研究、獣医)
・プロカルシトニンのアメリカ市場規模と予測2016-2021
・プロカルシトニンのヨーロッパ市場規模と予測2016-2021
・プロカルシトニンの中国市場規模と予測2016-2021
・プロカルシトニンの日本市場規模と予測2016-2021
・プロカルシトニンの東南アジア市場規模と予測2016-2021
・プロカルシトニンのインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Thermo Fisher、Roche Diagnostics、bioMerieux、HyTest、BBI Solutions、ProSpec、Wondfo、Ningbo Medicalsystem Biotechnology、Wuhan Easy Diagnosis Biomedicine、Snibe、Vazyme Biotech、Getein Biotech、Hotgen Biotech、Lumigenex、Nanjing Norman Biological Technology、Kitgen、Beijing KeyGen、Beijing Apis)
・プロカルシトニンの製造コスト分析
・販売チャネル、流通業者、顧客
・プロカルシトニンの市場動向・機会・課題
・調査の結論
【レポートの概要】

Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
Thermo Fisher was the world’s biggest manufacturer in the Procalcitonin (CAS 56645-65-9) industry, accounted for 13% market share of the global market, followed by Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology, Wuhan Easy Diagnosis Biomedicine, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Nanjing Norman Biological Technology, Kitgen, Beijing KeyGen, Beijing Apis.The top 5 companies had a combined market share of 35% of the global total.Europe was the largest consumption and production area in the world in 2018.

Market Analysis and Insights: Global Procalcitonin (CAS 56645-65-9) Market
The global Procalcitonin (CAS 56645-65-9) market was valued at US$ 76 in 2020 and will reach US$ 116.4 million by the end of 2027, growing at a CAGR of 7.3% during 2022-2027.

Global Procalcitonin (CAS 56645-65-9) Scope and Market Size
The global Procalcitonin (CAS 56645-65-9) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Procalcitonin (CAS 56645-65-9) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Procalcitonin Antigen
Procalcitonin Antibody
The segment of antigen holds a comparatively larger share in global market, which accounts for about 70%.

Segment by Application
Medical Industry
Scientific Research
Veterinarian
The medical industry holds an important share in terms of applications, and accounts for 90% of the market share.

The Procalcitonin (CAS 56645-65-9) market is analysed and market size information is provided by regions (countries). Segment by Application, the Procalcitonin (CAS 56645-65-9) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Kitgen
Beijing KeyGen
Beijing Apis

【レポートの目次】

1 Procalcitonin (CAS 56645-65-9) Market Overview
1.1 Procalcitonin (CAS 56645-65-9) Product Scope
1.2 Procalcitonin (CAS 56645-65-9) Segment by Type
1.2.1 Global Procalcitonin (CAS 56645-65-9) Sales by Type (2016 & 2021 & 2027)
1.2.2 Procalcitonin Antigen
1.2.3 Procalcitonin Antibody
1.3 Procalcitonin (CAS 56645-65-9) Segment by Application
1.3.1 Global Procalcitonin (CAS 56645-65-9) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Medical Industry
1.3.3 Scientific Research
1.3.4 Veterinarian
1.4 Procalcitonin (CAS 56645-65-9) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Procalcitonin (CAS 56645-65-9) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Procalcitonin (CAS 56645-65-9) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Procalcitonin (CAS 56645-65-9) Price Trends (2016-2027)

2 Procalcitonin (CAS 56645-65-9) Estimates and Forecasts by Region
2.1 Global Procalcitonin (CAS 56645-65-9) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Procalcitonin (CAS 56645-65-9) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Procalcitonin (CAS 56645-65-9) Sales Market Share by Region (2016-2021)
2.2.2 Global Procalcitonin (CAS 56645-65-9) Revenue Market Share by Region (2016-2021)
2.3 Global Procalcitonin (CAS 56645-65-9) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Procalcitonin (CAS 56645-65-9) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Procalcitonin (CAS 56645-65-9) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Procalcitonin (CAS 56645-65-9) Estimates and Projections (2016-2027)
2.4.2 Europe Procalcitonin (CAS 56645-65-9) Estimates and Projections (2016-2027)
2.4.3 China Procalcitonin (CAS 56645-65-9) Estimates and Projections (2016-2027)
2.4.4 Japan Procalcitonin (CAS 56645-65-9) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Procalcitonin (CAS 56645-65-9) Estimates and Projections (2016-2027)
2.4.6 India Procalcitonin (CAS 56645-65-9) Estimates and Projections (2016-2027)
3 Global Procalcitonin (CAS 56645-65-9) Competition Landscape by Players
3.1 Global Top Procalcitonin (CAS 56645-65-9) Players by Sales (2016-2021)
3.2 Global Top Procalcitonin (CAS 56645-65-9) Players by Revenue (2016-2021)
3.3 Global Procalcitonin (CAS 56645-65-9) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Procalcitonin (CAS 56645-65-9) as of 2020)
3.4 Global Procalcitonin (CAS 56645-65-9) Average Price by Company (2016-2021)
3.5 Manufacturers Procalcitonin (CAS 56645-65-9) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Procalcitonin (CAS 56645-65-9) Market Size by Type
4.1 Global Procalcitonin (CAS 56645-65-9) Historic Market Review by Type (2016-2021)
4.1.1 Global Procalcitonin (CAS 56645-65-9) Sales Market Share by Type (2016-2021)
4.1.2 Global Procalcitonin (CAS 56645-65-9) Revenue Market Share by Type (2016-2021)
4.1.3 Global Procalcitonin (CAS 56645-65-9) Price by Type (2016-2021)
4.2 Global Procalcitonin (CAS 56645-65-9) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Procalcitonin (CAS 56645-65-9) Sales Forecast by Type (2022-2027)
4.2.2 Global Procalcitonin (CAS 56645-65-9) Revenue Forecast by Type (2022-2027)
4.2.3 Global Procalcitonin (CAS 56645-65-9) Price Forecast by Type (2022-2027)
5 Global Procalcitonin (CAS 56645-65-9) Market Size by Application
5.1 Global Procalcitonin (CAS 56645-65-9) Historic Market Review by Application (2016-2021)
5.1.1 Global Procalcitonin (CAS 56645-65-9) Sales Market Share by Application (2016-2021)
5.1.2 Global Procalcitonin (CAS 56645-65-9) Revenue Market Share by Application (2016-2021)
5.1.3 Global Procalcitonin (CAS 56645-65-9) Price by Application (2016-2021)
5.2 Global Procalcitonin (CAS 56645-65-9) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Procalcitonin (CAS 56645-65-9) Sales Forecast by Application (2022-2027)
5.2.2 Global Procalcitonin (CAS 56645-65-9) Revenue Forecast by Application (2022-2027)
5.2.3 Global Procalcitonin (CAS 56645-65-9) Price Forecast by Application (2022-2027)

6 North America Procalcitonin (CAS 56645-65-9) Market Facts & Figures
6.1 North America Procalcitonin (CAS 56645-65-9) Sales by Company
6.1.1 North America Procalcitonin (CAS 56645-65-9) Sales by Company (2016-2021)
6.1.2 North America Procalcitonin (CAS 56645-65-9) Revenue by Company (2016-2021)
6.2 North America Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type
6.2.1 North America Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type (2016-2021)
6.2.2 North America Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type (2022-2027)
6.3 North America Procalcitonin (CAS 56645-65-9) Sales Breakdown by Application
6.3.1 North America Procalcitonin (CAS 56645-65-9) Sales Breakdown by Application (2016-2021)
6.3.2 North America Procalcitonin (CAS 56645-65-9) Sales Breakdown by Application (2022-2027)

7 Europe Procalcitonin (CAS 56645-65-9) Market Facts & Figures
7.1 Europe Procalcitonin (CAS 56645-65-9) Sales by Company
7.1.1 Europe Procalcitonin (CAS 56645-65-9) Sales by Company (2016-2021)
7.1.2 Europe Procalcitonin (CAS 56645-65-9) Revenue by Company (2016-2021)
7.2 Europe Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type
7.2.1 Europe Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type (2022-2027)
7.3 Europe Procalcitonin (CAS 56645-65-9) Sales Breakdown by Application
7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)

8 China Procalcitonin (CAS 56645-65-9) Market Facts & Figures
8.1 China Procalcitonin (CAS 56645-65-9) Sales by Company
8.1.1 China Procalcitonin (CAS 56645-65-9) Sales by Company (2016-2021)
8.1.2 China Procalcitonin (CAS 56645-65-9) Revenue by Company (2016-2021)
8.2 China Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type
8.2.1 China Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type (2016-2021)
8.2.2 China Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type (2022-2027)
8.3 China Procalcitonin (CAS 56645-65-9) Sales Breakdown by Application
8.3.1 China 310 Sales Breakdown by Application (2016-2021)
8.3.2 China 310 Sales Breakdown by Application (2022-2027)

9 Japan Procalcitonin (CAS 56645-65-9) Market Facts & Figures
9.1 Japan Procalcitonin (CAS 56645-65-9) Sales by Company
9.1.1 Japan Procalcitonin (CAS 56645-65-9) Sales by Company (2016-2021)
9.1.2 Japan Procalcitonin (CAS 56645-65-9) Revenue by Company (2016-2021)
9.2 Japan Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type
9.2.1 Japan Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type (2022-2027)
9.3 Japan Procalcitonin (CAS 56645-65-9) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Procalcitonin (CAS 56645-65-9) Market Facts & Figures
10.1 Southeast Asia Procalcitonin (CAS 56645-65-9) Sales by Company
10.1.1 Southeast Asia Procalcitonin (CAS 56645-65-9) Sales by Company (2016-2021)
10.1.2 Southeast Asia Procalcitonin (CAS 56645-65-9) Revenue by Company (2016-2021)
10.2 Southeast Asia Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type
10.2.1 Southeast Asia Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Procalcitonin (CAS 56645-65-9) Sales Breakdown by Application
10.3.1 Southeast Asia mg Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia mg Sales Breakdown by Application (2022-2027)

11 India Procalcitonin (CAS 56645-65-9) Market Facts & Figures
11.1 India Procalcitonin (CAS 56645-65-9) Sales by Company
11.1.1 India Procalcitonin (CAS 56645-65-9) Sales by Company (2016-2021)
11.1.2 India Procalcitonin (CAS 56645-65-9) Revenue by Company (2016-2021)
11.2 India Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type
11.2.1 India Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type (2016-2021)
11.2.2 India Procalcitonin (CAS 56645-65-9) Sales Breakdown by Type (2022-2027)
11.3 India Procalcitonin (CAS 56645-65-9) Sales Breakdown by Application
11.3.1 India Procalcitonin (CAS 56645-65-9) Sales Breakdown by Application (2016-2021)
11.3.2 India Procalcitonin (CAS 56645-65-9) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Procalcitonin (CAS 56645-65-9) Business
12.1 Thermo Fisher
12.1.1 Thermo Fisher Corporation Information
12.1.2 Thermo Fisher Business Overview
12.1.3 Thermo Fisher Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Thermo Fisher Procalcitonin (CAS 56645-65-9) Products Offered
12.1.5 Thermo Fisher Recent Development
12.2 Roche Diagnostics
12.2.1 Roche Diagnostics Corporation Information
12.2.2 Roche Diagnostics Business Overview
12.2.3 Roche Diagnostics Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Roche Diagnostics Procalcitonin (CAS 56645-65-9) Products Offered
12.2.5 Roche Diagnostics Recent Development
12.3 bioMerieux
12.3.1 bioMerieux Corporation Information
12.3.2 bioMerieux Business Overview
12.3.3 bioMerieux Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 bioMerieux Procalcitonin (CAS 56645-65-9) Products Offered
12.3.5 bioMerieux Recent Development
12.4 HyTest
12.4.1 HyTest Corporation Information
12.4.2 HyTest Business Overview
12.4.3 HyTest Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 HyTest Procalcitonin (CAS 56645-65-9) Products Offered
12.4.5 HyTest Recent Development
12.5 BBI Solutions
12.5.1 BBI Solutions Corporation Information
12.5.2 BBI Solutions Business Overview
12.5.3 BBI Solutions Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 BBI Solutions Procalcitonin (CAS 56645-65-9) Products Offered
12.5.5 BBI Solutions Recent Development
12.6 ProSpec
12.6.1 ProSpec Corporation Information
12.6.2 ProSpec Business Overview
12.6.3 ProSpec Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 ProSpec Procalcitonin (CAS 56645-65-9) Products Offered
12.6.5 ProSpec Recent Development
12.7 Wondfo
12.7.1 Wondfo Corporation Information
12.7.2 Wondfo Business Overview
12.7.3 Wondfo Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Wondfo Procalcitonin (CAS 56645-65-9) Products Offered
12.7.5 Wondfo Recent Development
12.8 Ningbo Medicalsystem Biotechnology
12.8.1 Ningbo Medicalsystem Biotechnology Corporation Information
12.8.2 Ningbo Medicalsystem Biotechnology Business Overview
12.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Ningbo Medicalsystem Biotechnology Procalcitonin (CAS 56645-65-9) Products Offered
12.8.5 Ningbo Medicalsystem Biotechnology Recent Development
12.9 Wuhan Easy Diagnosis Biomedicine
12.9.1 Wuhan Easy Diagnosis Biomedicine Corporation Information
12.9.2 Wuhan Easy Diagnosis Biomedicine Business Overview
12.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Wuhan Easy Diagnosis Biomedicine Procalcitonin (CAS 56645-65-9) Products Offered
12.9.5 Wuhan Easy Diagnosis Biomedicine Recent Development
12.10 Snibe
12.10.1 Snibe Corporation Information
12.10.2 Snibe Business Overview
12.10.3 Snibe Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Snibe Procalcitonin (CAS 56645-65-9) Products Offered
12.10.5 Snibe Recent Development
12.11 Vazyme Biotech
12.11.1 Vazyme Biotech Corporation Information
12.11.2 Vazyme Biotech Business Overview
12.11.3 Vazyme Biotech Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Vazyme Biotech Procalcitonin (CAS 56645-65-9) Products Offered
12.11.5 Vazyme Biotech Recent Development
12.12 Getein Biotech
12.12.1 Getein Biotech Corporation Information
12.12.2 Getein Biotech Business Overview
12.12.3 Getein Biotech Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Getein Biotech Procalcitonin (CAS 56645-65-9) Products Offered
12.12.5 Getein Biotech Recent Development
12.13 Hotgen Biotech
12.13.1 Hotgen Biotech Corporation Information
12.13.2 Hotgen Biotech Business Overview
12.13.3 Hotgen Biotech Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Hotgen Biotech Procalcitonin (CAS 56645-65-9) Products Offered
12.13.5 Hotgen Biotech Recent Development
12.14 Lumigenex
12.14.1 Lumigenex Corporation Information
12.14.2 Lumigenex Business Overview
12.14.3 Lumigenex Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Lumigenex Procalcitonin (CAS 56645-65-9) Products Offered
12.14.5 Lumigenex Recent Development
12.15 Nanjing Norman Biological Technology
12.15.1 Nanjing Norman Biological Technology Corporation Information
12.15.2 Nanjing Norman Biological Technology Business Overview
12.15.3 Nanjing Norman Biological Technology Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Nanjing Norman Biological Technology Procalcitonin (CAS 56645-65-9) Products Offered
12.15.5 Nanjing Norman Biological Technology Recent Development
12.16 Kitgen
12.16.1 Kitgen Corporation Information
12.16.2 Kitgen Business Overview
12.16.3 Kitgen Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Kitgen Procalcitonin (CAS 56645-65-9) Products Offered
12.16.5 Kitgen Recent Development
12.17 Beijing KeyGen
12.17.1 Beijing KeyGen Corporation Information
12.17.2 Beijing KeyGen Business Overview
12.17.3 Beijing KeyGen Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Beijing KeyGen Procalcitonin (CAS 56645-65-9) Products Offered
12.17.5 Beijing KeyGen Recent Development
12.18 Beijing Apis
12.18.1 Beijing Apis Corporation Information
12.18.2 Beijing Apis Business Overview
12.18.3 Beijing Apis Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Beijing Apis Procalcitonin (CAS 56645-65-9) Products Offered
12.18.5 Beijing Apis Recent Development

13 Procalcitonin (CAS 56645-65-9) Manufacturing Cost Analysis
13.1 Procalcitonin (CAS 56645-65-9) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Procalcitonin (CAS 56645-65-9)
13.4 Procalcitonin (CAS 56645-65-9) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Procalcitonin (CAS 56645-65-9) Distributors List
14.3 Procalcitonin (CAS 56645-65-9) Customers

15 Market Dynamics
15.1 Procalcitonin (CAS 56645-65-9) Market Trends
15.2 Procalcitonin (CAS 56645-65-9) Drivers
15.3 Procalcitonin (CAS 56645-65-9) Market Challenges
15.4 Procalcitonin (CAS 56645-65-9) Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のプロカルシトニン販売市場2021(Global Procalcitonin (CAS 56645-65-9) Sales Market Report 2021)]についてメールでお問い合わせはこちらでお願いします。